Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammation × Dermatologic × 90 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 2 Gynecologic 2 Gastrointestinal 2 Breast 2 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Melanoma 342 Carcinoma, Non-Small-Cell Lung 78 Skin Neoplasms 73 Carcinoma, Renal Cell 49 Uveal Melanoma 46 Neoplasm Metastasis 46 Lung Neoplasms 39 Colorectal Neoplasms 39 Breast Neoplasms 39 Neoplasms 37 Squamous Cell Carcinoma of Head and Neck 36 Ovarian Neoplasms 36 Carcinoma, Basal Cell 35 Carcinoma, Merkel Cell 30 Sarcoma 26 Lymphoma, T-Cell, Cutaneous 26 Pancreatic Neoplasms 24 Carcinoma, Hepatocellular 24 Stomach Neoplasms 23 Uterine Cervical Neoplasms 22 Urinary Bladder Neoplasms 21 Prostatic Neoplasms 20 Esophageal Neoplasms 19 Endometrial Neoplasms 19 Thyroid Neoplasms 18 Carcinoma, Squamous Cell 17 Brain Neoplasms 17 Head and Neck Neoplasms 16 Carcinoma, Transitional Cell 15 Triple Negative Breast Neoplasms 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07138222 2026-01-28

IMPACT

Peter MacCallum Cancer Centre, Australia

Inflammation, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡